(Q83661349)
Statements
Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis (English)
J Theodore Phillips
Gavin Giovannoni
Fred D Lublin
Paul W O'Connor
Chris H Polman
Ernie Willoughby
William Aschenbach
Amy Pace
Robert Hyde
Frederick E Munschauer
18 March 2011